SKI Market

A+| A| A-|

Indian Indices

Sensex

73,319.55 185.23
( 0.25%)

Global Indices

Nasdaq

46,526.80 -59.95
(-0.13%)

Dow Jones

6,603.92 7.60
(0.12%)

Hang Seng

53,162.49 699.22
(1.33%)

Nikkei 225

10,436.29 71.50
(0.69%)

Forex

USD-INR

93.17 -0.69
(-0.73%)

EUR-INR

107.97 0.00
(0.00%)

GBP-INR

123.80 -0.23
(-0.19%)

JPY-INR

0.59 0.00
(-0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5510998

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

21.9

101627.83

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.66

Back

Laxmi Goldorna House standalone net profit declines 8.29% in the September 2025 quarter

Oct 14,2025

Net profit of Laxmi Goldorna House declined 8.29% to Rs 3.76 crore in the quarter ended September 2025 as against Rs 4.10 crore during the previous quarter ended September 2024. Sales rose 12.55% to Rs 24.85 crore in the quarter ended September 2025 as against Rs 22.08 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	24.85	22.08	13
OPM %	30.22	33.15	-
PBDT	4.59	5.03	-9
PBT	4.54	4.98	-9
NP	3.76	4.10	-8

73,319.55 185.23 ( 0.25%)

46,526.80 -59.95 (-0.13%)

6,603.92 7.60 (0.12%)

53,162.49 699.22 (1.33%)

10,436.29 71.50 (0.69%)

93.17 -0.69 (-0.73%)

107.97 0.00 (0.00%)

123.80 -0.23 (-0.19%)

0.59 0.00 (-0.32%)